Department for Transport

Contingencies Fund Advance

Baroness Vere of Norbiton: My Right Honourable friend, the Secretary of State for Transport (Grant Shapps), has made the following Ministerial Statement.I hereby give notice of the Department for Transport having drawn advances from the Contingencies Fund totalling £4,000,000,000 to enable expenditure on COVID-19 support packages to be spent ahead of the passage of the Supply and Appropriation Act. The schemes include:Emergency Recovery Measures Agreements with the Train Operating Companies; the COVID-19 Bus Services Support Grant; safeguarding critical ferry freight routes; and supporting regional transport networks such as Transport for London and light rail networks.Parliamentary approval for additional resource of £4,000,000,000 will be sought in a Supplementary Estimate for the Department for Transport. Pending that approval, urgent expenditure estimated at £4,000,000,000 will be met by repayable cash advances from the Contingencies Fund.The cash advance will be repaid upon receiving Royal Assent of the Supply and Appropriation (Anticipation and Adjustments) Bill.

Department for Business, Energy and Industrial Strategy

Research and Development Update

Lord Callanan: My Honourable friend the Minister for Science, Research and Innovation (Amanda Solloway) has today made the following statement:I am tabling this statement for the benefit of Honourable and Right Honourable Members, to bring to their attention the support that the Government is providing to United Kingdom Research and Innovation (UKRI) funded doctoral students to address the challenges related to COVID-19 restrictions. When lockdown began last year, UKRI communicated immediately that PhD studentships should not be suspended ensuring students could continue to receive their stipends. In April 2020, £44m of urgent funding was announced for up to 6-month extensions for PhD students in their final year who could not complete their studies as originally planned due to COVID-19 restrictions. This was taken up by 77% of eligible students. In November 2020, a further £19.1m was allocated to Research Organisations hosting UKRI funded students. This enabled those organisations to target additional support to those UKRI funded students who needed it most including those whose study had been impacted by caring responsibilities or health reasons, and those in their final year. These two phases of funding amount to £63m of funding and will provide support to approximately 10,000 students. Since the introduction of the current restrictions in January, the Government has continued to monitor the impact on the research sector. I asked UKRI to explore what else could be done to help and I can now confirm that we will be providing additional support to UKRI funded PhD students. A further £7m will now be made available to allocate extensions, based on need, to those students still to complete their studies. Additionally, UKRI are exploring options to increase flexibility for grant holding organisations to allocate existing funding for training and cohort development activity to fund extensions. Research England will also be delivering around £11m of block grant funding to English universities as a contribution to their support for their postgraduate research communities, including to students funded by universities themselves and to self-financed students. By the end of this phase of support funding, UKRI will have provided additional support totalling £70m, including extensions, to around half of all their funded students who were studying at the start of the first lockdown extension. This support has been targeted at those most in need and with equality, diversity and inclusion considered throughout. Ensuring that the research sector in the UK has the people and skills it needs is crucial to realising Government’s ambition to cement our status as a science superpower. We will continue to monitor this situation closely, to ensure that we are able to consider additional support if necessary.

Advanced Research and Invention Agency

Lord Callanan: My Right Honourable friend the Secretary of State for Business, Energy and Industrial Strategy Kwasi Kwarteng has today made the following statement:The UK has a proud history of scientific excellence and invention. Charles Babbage, Ada Lovelace, and later, Alan Turing pioneered early predecessors of the computer. Thomas Newcomen and James Watt gave us the steam engine, and Michael Faraday gave us the modern battery. This Government is committed to continuing this tradition and cementing our role as a science superpower. That is why our manifesto committed to creating a new funding agency, focused on high-risk, high-reward research. I am pleased to update the House that we will be fulfilling this commitment through a new Advanced Research and Invention Agency (ARIA), and we will also be introducing a Bill as soon as parliamentary time allows to create this body. ARIA will have the sole focus to fund ground-breaking research – research that sparks transformational societal change through the creation of new technologies and new industries. With £800 million committed to ARIA up to 2024/25, ARIA will form a central part of delivering on our R&D Roadmap, published in July 2020, to ensure the UK is the best place for scientists, researchers, and entrepreneurs to live and work, while helping to power up the UK’s economic and social recovery. As we have developed ARIA, we have sought best practice from international partners. Success stories include DARPA in the US, whose predecessor, ARPA, was instrumental in creating transformational technologies like the internet and GPS. More recently, DARPA has been behind precursors to technologies such as Apple’s SIRI. We have also listened to the scientific community about how these models can best be adapted for the UK to enhance our R&D offer. This includes ensuring ARIA complements existing funders and makes a distinct contribution to the wider R&D landscape. To this end, ARIA will have a bespoke purpose and structure, and will work in partnership with UKRI and across the ecosystem. ARIA’s key features will be: A singular focus on high-risk, high reward research funding. ARIA will provide support for transformational, long-term science and technology. ARIA will not be restricted in whether it funds pure science, applied science, or technological development – in fact, often it will do aspects of each within a single programme. A high tolerance for risk and failure. Failure is part of the scientific process, and particularly central to finding the technological breakthroughs that have the potential to create the industries and jobs of the future. ARIA will not shy away from high risk, in the pursuit of high rewards. Minimal bureaucracy. The recent approach to COVID rapid response funds and the Vaccine Taskforce has led to a cultural shift around funding and decision-making, towards a more lean and agile system, and ARIA will continue this trend. It will have an innovative approach to funding, with the ability to use mechanisms such as seed grants and prizes to ensure the best support for the best ideas. ARIA’s programme managers will be able to pull in scientists on projects within in a matter of weeks. To empower exceptional talent. ARIA will be run by exceptional scientists who have the expertise to identify the most exciting and ground-breaking research to invest in. Government will invest in these exceptional individuals, empowering them to use their expertise to identify what research to back rather than providing a research focus for the organisation, and giving them the freedom to start and stop projects quickly and redirect funding efficiently. Alongside the Bill, we will recruit a visionary CEO and experienced Chair. They will develop ARIA by setting the agenda, shaping the culture, and building an exceptional team for the agency. ARIA will further diversify our rich and dynamic R&D system, taking us to the next level of scientific and technological advances. Its successes stand to have an impact for how we fund R&D in the future, and ensure we maintain our outstanding global reputation for innovation and discovery.

Departmental Contingent Liability Notification (UKAEA Fusion Liabilities)

Lord Callanan: My Honourable friend the Minister for Science, Research and Innovation (Amanda Solloway) has today made the following statement:I am tabling this statement for the benefit of Honourable and Right Honourable Members to bring to their attention the details of an amendment to the Contingent Liability for the fusion activities of the UK Atomic Energy Authority, here on referred to as UKAEA. UKAEA operate experimental fusion reactors at Culham, Oxfordshire. Under the Nuclear Installations Act 1965, UKAEA are required to meet any third-party liabilities arising from an onsite incident resulting in exposure to ionising radiation. A remote and unquantified contingent liability is in place which provides cover for such liabilities above £2.25m. UKAEA’s captive insurer previously provided cover for such liabilities up to £2.25 million. This was wound up in 2019 as it did not provide good value for money to the taxpayer. Commercial arrangements to replace the captive insurer and cover nuclear liabilities – either in part or in full – would not provide good value for money. The best value for money for taxpayers would be to amend the existing remote unquantified contingent liability held by BEIS to include all costs arising from exposure to ionising radiation due to the fusion activities of UKAEA. This contingent liability will remain remote and unquantified. There is no expiry date so will be reviewed annually to ensure it continues to be good value for money for the taxpayer. The Government will be subject to a new contingent liability for all liabilities from UKAEA fusion activities that lead to exposure to ionising radiation, and I will be laying a Departmental Minute today containing a description of the liability undertaken.